Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $759,291 - $1.05 Million
3,900 Added 90.7%
8,200 $2.19 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $206,294 - $245,322
-1,100 Reduced 20.37%
4,300 $877,000
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $678,195 - $854,490
3,500 Added 184.21%
5,400 $1.14 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $2.04 Million - $2.62 Million
-9,100 Reduced 82.73%
1,900 $456,000
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $452,784 - $590,480
1,600 Added 17.02%
11,000 $3.11 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $2.43 Million - $3.9 Million
9,400 New
9,400 $3.26 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.